Clinical trials are essential for evaluating potential new treatments, advancing the standard of care, and improving patient outcomes, yet only about five percent of Americans participate in ...

People often reject trial participation because they ... more about them and if they are a good fit. Other barriers for people considering a clinical trial include eligibility and costs.

This sounds entirely obvious but failure to translate this insight into more innovative patient support contributes to the ...

In this video interview, Michel van Harten, MD, CEO, myTomorrows, discusses how patient education and remote monitoring can help with reducing the burden of trial participation.

Clinical trials are essential for advancing medical treatments, yet participation from Black communities remains low due to misinformation.

If the future of oncology research is to be inclusive, efficient, and representative, community-based clinical trials must be ...

Removing barriers to clinical trial participation for underserved groups is an essential part of addressing health inequalities. Getting there, however, is easier said than done. The Food and Drug ...

Calif., who represents Imperial County, and Rep. August Pfluger, R-Texas, introduced bipartisan legislation aimed at removing ...

In recognition of Clinical Trials Day, the Coalition to Transform Clinical Trial Engagement (CTCTE) proudly announces the launch of the Champions for Change ...

Clinical trials are essential for evaluating potential new treatments, advancing the standard of care, and improving patient outcomes, yet only about five percent of Americans participate in them.